Neuroen

eNIT AI operates in the mental healthcare technology sector with its Evidence-based Treatment AI System, a Clinical Decision Support System (CDSS). The system is designed for use in clinical settings, such as hospitals, to assist medical professionals in diagnosing and prescribing treatments for mental health conditions.

The process begins with the collection of patient-specific brain function data through tests like TCI, HRV, qEEG, and CPT. The AI platform then analyzes this data to provide evidence-based treatment recommendations. These suggestions include specific interventions like repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and targeted pharmacotherapy.

The business model appears to be B2B, providing this CDSS to hospitals and mental health clinics to enhance diagnostic accuracy and create more efficient, personalized treatment plans for patients. Revenue is likely generated through licensing the AI system to these healthcare providers.

Keywords: Mental Healthcare, Clinical Decision Support, AI, Brain Data Analysis, qEEG, Pharmacotherapy, rTMS, tDCS, MedTech, Neurotechnology